36 related news articles for Regulation of Interferon and Innate Signalling

The frontline of defences against viruses and other pathogens will be fortified by the creation of a new Centre of Research Excellence for Nucleic Acid Sensing, located at Hudson Institute. …  Read more

Hudson Institute of Medical Research has been recognised as a leader in RNA based medicine, with new federal government funding set to accelerate the search for new and better treatments.…  Read more

Their latest research, published in the esteemed journal, Nature, showed that the innate immune system produces a powerful weapon against ovarian cancer – interferon epsilon (IFNe) – a weapon just waiting to be harnessed to deliver an effective immunotherapy treatment option.…  Read more

Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

In a distinguished scientific career lasting four decades, Professor Paul Hertzog has just about seen it all – but seeing his team’s latest research published in the influential journal Nature was a proud moment.…  Read more

The search for preventions and cures has turned inward – focussing on the immune system to stop ovarian cancer.…  Read more

Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.…  Read more

Researchers are taking a new approach to a debilitating illness by looking for a microbiome-based cause of Inflammatory Bowel Disease (IBD).…  Read more

The COVID-19 pandemic made RNA a topic of everyday discussion – suddenly, it was everywhere. For many Hudson Institute scientists, that meant an unprecedented level of interest in something they had spent many years studying. …  Read more

Congratulations to the recipients of the 2023 Harold Mitchell Travel Fellowships, provided by the Harold Mitchell Foundation to give young scientists much-needed opportunities for to expand their horizons.…  Read more

Six of the best early career researchers have been chosen to take part in the Hudson Institute 2023 Emerging Leaders Program. …  Read more

Congratulations to Professor Ron Firestein, who was announced this week as Deputy Director of Hudson Institute of Medical Research.…  Read more

The body’s first line of defence against infection is now better understood, with researchers at Hudson Institute identifying a source of the immune system’s protection against STIs (sexually transmitted infections).…  Read more

This inflammatory condition affecting the digestive system can seriously impact people’s lives – so what is Crohn’s disease and how is it treated?…  Read more

A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Rachel Botros has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings also have the disease. …  Read more

Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.…  Read more

Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. …  Read more

A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.…  Read more

A team of leading Australian scientists have published research which transforms existing perceptions of T cell recognition.…  Read more

New and improved treatments for many serious ailments could follow a prestigious $5 million NHMRC Synergy grant to a team led by Hudson Institute of Medical Research scientists.…  Read more

Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.…  Read more

The introduction of faecal transplants has provided a new and welcome approach to treating difficult bacterial infections. However, following a patient death, there are questions over their future use. How can the risks surrounding transplants be removed to reap the benefits of this promising therapeutic treatment?…  Read more

More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

Hudson Institute has had excellent success in the recent NHMRC and ARC Grant rounds.…  Read more

A new study into tuberculosis has revealed a novel target – hidden in a gene – that could reduce susceptibility to one of the world’s most deadly diseases. The study involved scientists at Hudson Institute of Medical Research and was led by Centenary Institute scientists, Dr Warwick Britton and Dr Carl Feng at the University…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Scientists from Hudson Institute of Medical Research and Deakin University have shown that a naturally occurring signalling protein found in the female reproductive tract, interferon epsilon, can block the replication of human immunodeficiency virus (HIV) in human cells, and could form a first-line response to the virus.…  Read more

Hudson Institute of Medical Research researchers have been awarded National Health and Medical Research Council Fellowships in the latest funding announcements.…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

A group of students from the John Monash Science School experienced the future of science during a Discovery Tour at Hudson Institute of Medical Research to celebrate International Day of Immunology.…  Read more

The MIMR-PHI Institute of Medical Research has received $1M AUD from the Bill and Melinda Gates Foundation to investigate the relationship between some oral contraceptives and an increased susceptibility to sexually transmitted infections (STIs), including HIV.…  Read more